---
figid: PMC9256076__IJO-61-2-05383-g00
figtitle: Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment
  (Review)
organisms:
- Homo sapiens
- Mus musculus
- Olea europaea
pmcid: PMC9256076
filename: IJO-61-2-05383-g00.jpg
figlink: /pmc/articles/PMC9256076/figure/f1-ijo-61-2-05383/
number: F1
caption: Metabolic pathways utilized by pancreatic cancer cells. Upward arrows represent
  upregulation and T-bars represent inhibition. Red lettering indicates deregulated
  genes, proteins and processes. ACS, acetyl-CoA synthetase; Arg, arginine; ASCT2,
  alanine serine cysteine transporter 2; Asp, aspartate; BCAAs, branched-chain amino
  acids; BCAT1/2, branched-chain aminotransferase 1/2; BCKAs, branched-chain keto
  acids; CPSII, carbamoyl phosphate synthase II; EMT, epithelial-mesenchymal transition;
  F-1,6BP, fructose 1,6-bisphosphate; F-6P, fructose 6-phosphate; FA, fatty acid;
  FASN, fatty acid synthase; G-6P, glucose 6-phosphate; GFAT, glutamine fructose-6-phosphate
  amidotransferase; GlcN-6P, glucosamine-6-phosphate; Gln, glutamine; GLS1/GLS2, glutaminase
  1/2; Glu, glutamate; GLUT1, glucose transporter 1; GOT1/GOT2, glutamate oxaloacetate
  transaminase 1/2; GPAT, glycerol-3-phosphate acyltransferase; GSH, glutathione;
  GSSG, glutathione disulfide; HIF1α/HIF2α, hypoxia-inducible factor 1-α/2-α; HIF1β,
  hypoxia-inducible factor 1-β; HK1/2, hexokinase 1/2; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme
  A reductase; Farnesyl-PP, farnesyl pyrophosphate; Ile, isoleucine; LDLR, low-density
  lipoprotein receptor; Leu, leucine; lncRNA XLOC_006390, long non-coding RNA XLOC_006390;
  MCT1/MCT4, monocarboxylate transporter 1/4; ME2, malic enzyme 2; ME3, malic enzyme
  3; mTORC1/mTORC2, mechanistic target of rapamycin complex 1/2; MUFA, monounsaturated
  fatty acid; Mutp53, mutant p53; NAD+, nicotinamide adenine dinucleotide; NADH, reduced
  form of nicotinamide adenine dinucleotide; NADP+, nicotinamide adenine dinucleotide
  phosphate; NADPH, reduced form of nicotinamide adenine dinucleotide phosphate; NEAA,
  non-essential amino acids; NO, nitric oxide; OAA, oxaloacetate; PDH, pyruvate dehydrogenase;
  PFK1, phosphofructokinase-1; Pi, inorganic phosphate; PI3K, phosphoinositide 3-kinase;
  PKM2, pyruvate kinase M2; PPP, pentose phosphate pathway; PUFA, polyunsaturated
  fatty acid; SCD1, stearoyl-CoA desaturase 1; SFA, saturated fatty acid; UB, ubiquitin;
  UCP2, uncoupling protein 2; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine;
  Val, valine; α-KG, α-ketoglutarate.
papertitle: Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment
  (Review).
reftext: Michal Zuzčák, et al. Int J Oncol. 2022 Aug;61(2):93.
year: '2022'
doi: 10.3892/ijo.2022.5383
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos
keywords: pancreatic cancer | metabolic profiling | glycolysis | amino acid metabolism
  | mitochondrial oxidative metabolism | tumor microenvironment | cancer stem cells
  | cell metabolism | chemoresistance
automl_pathway: 0.8470172
figid_alias: PMC9256076__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9256076__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9256076__IJO-61-2-05383-g00.html
  '@type': Dataset
  description: Metabolic pathways utilized by pancreatic cancer cells. Upward arrows
    represent upregulation and T-bars represent inhibition. Red lettering indicates
    deregulated genes, proteins and processes. ACS, acetyl-CoA synthetase; Arg, arginine;
    ASCT2, alanine serine cysteine transporter 2; Asp, aspartate; BCAAs, branched-chain
    amino acids; BCAT1/2, branched-chain aminotransferase 1/2; BCKAs, branched-chain
    keto acids; CPSII, carbamoyl phosphate synthase II; EMT, epithelial-mesenchymal
    transition; F-1,6BP, fructose 1,6-bisphosphate; F-6P, fructose 6-phosphate; FA,
    fatty acid; FASN, fatty acid synthase; G-6P, glucose 6-phosphate; GFAT, glutamine
    fructose-6-phosphate amidotransferase; GlcN-6P, glucosamine-6-phosphate; Gln,
    glutamine; GLS1/GLS2, glutaminase 1/2; Glu, glutamate; GLUT1, glucose transporter
    1; GOT1/GOT2, glutamate oxaloacetate transaminase 1/2; GPAT, glycerol-3-phosphate
    acyltransferase; GSH, glutathione; GSSG, glutathione disulfide; HIF1α/HIF2α, hypoxia-inducible
    factor 1-α/2-α; HIF1β, hypoxia-inducible factor 1-β; HK1/2, hexokinase 1/2; HMG-CoA,
    3-hydroxy-3-methylglutaryl-coenzyme A reductase; Farnesyl-PP, farnesyl pyrophosphate;
    Ile, isoleucine; LDLR, low-density lipoprotein receptor; Leu, leucine; lncRNA
    XLOC_006390, long non-coding RNA XLOC_006390; MCT1/MCT4, monocarboxylate transporter
    1/4; ME2, malic enzyme 2; ME3, malic enzyme 3; mTORC1/mTORC2, mechanistic target
    of rapamycin complex 1/2; MUFA, monounsaturated fatty acid; Mutp53, mutant p53;
    NAD+, nicotinamide adenine dinucleotide; NADH, reduced form of nicotinamide adenine
    dinucleotide; NADP+, nicotinamide adenine dinucleotide phosphate; NADPH, reduced
    form of nicotinamide adenine dinucleotide phosphate; NEAA, non-essential amino
    acids; NO, nitric oxide; OAA, oxaloacetate; PDH, pyruvate dehydrogenase; PFK1,
    phosphofructokinase-1; Pi, inorganic phosphate; PI3K, phosphoinositide 3-kinase;
    PKM2, pyruvate kinase M2; PPP, pentose phosphate pathway; PUFA, polyunsaturated
    fatty acid; SCD1, stearoyl-CoA desaturase 1; SFA, saturated fatty acid; UB, ubiquitin;
    UCP2, uncoupling protein 2; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine;
    Val, valine; α-KG, α-ketoglutarate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mcph1
  - Kras
  - Cd14
  - Arid4b
  - Slc1a5
  - Mxd1
  - Hk1
  - oh
  - Pate1
  - Bcat1
  - Plaat5
  - Ephb2
  - Mapk1
  - Gnas
  - Hps3
  - Decr1
  - Myc
  - Nol3
  - Ucp2
  - ac
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Aap
  - S100a11
  - Fblim1
  - Gopc
  - Car1
  - Pdia4
  - Abl2
  - Rere
  - Albfm1
  - Trp53
  - fa
  - Ad
  - Itk
  - Slc22a3
  - Cd36
  - Scarb1
  - ap
  - SLC16A1
  - MCAT
  - MCPH1
  - KRAS
  - NRAS
  - CD14
  - NDUFA2
  - ARID4B
  - SLC1A5
  - AMPD1
  - MXD1
  - HK1
  - KCNA4
  - KLK1
  - HOOK1
  - TAC4
  - PATE1
  - BCAT1
  - PLAAT5
  - AKR1A1
  - ARMC9
  - EPHB2
  - MAPK1
  - MAPK3
  - GNAS
  - DECR1
  - GOT1
  - GOT2
  - COX1
  - MYC
  - UCP2
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - FCRL3
  - DELYQ11
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PUM3
  - SERPINF2
  - FBLIM1
  - GOPC
  - CA1
  - ABL2
  - RERE
  - TP53
  - TP63
  - TP73
  - ITK
  - SLC22A3
  - CD36
---
